Is Orchid Pharma Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Orchid Pharma Ltd and arrived at the following conclusion.

Is the current market price of Orchid Pharma Ltd a good price to buy it?

The 5-year analysis of Orchid Pharma Ltd's performance infers.

What is Orchid Pharma Ltd share price return in the past 10 years?

We analysed the performance of Orchid Pharma Ltd share prices over the last 10 years. Here is what we found out:

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Orchid Pharma Ltd

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

What is CAGR? What does CAGR table indicate for Orchid Pharma Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Orchid Pharma informs about company updates

Orchid Pharma Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524372 | NSE: ORCHPHARMA

31 Dec 2015

Evaluate

Orchid Pharma has informed that the company received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection closure for the formulation manufacturing facility located at Irungattukottai, Sriperumbudur, Kancheepuram District, India. The facility was inspected by USFDA in the month of May 2015.

The above information is a part of company’s filings submitted to BSE.

Related Orchid Pharma Ltd. Links:

Analysis

Reports

News

Stock Price

Sector News